137 related articles for article (PubMed ID: 10770493)
1. Prolactin (PRL)-PRL receptor system increases cell proliferation involving JNK (c-Jun amino terminal kinase) and AP-1 activation: inhibition by glucocorticoids.
Olazabal I; Muñoz J; Ogueta S; Obregón E; García-Ruiz JP
Mol Endocrinol; 2000 Apr; 14(4):564-75. PubMed ID: 10770493
[TBL] [Abstract][Full Text] [Related]
2. Prolactin stimulates activation of c-jun N-terminal kinase (JNK).
Schwertfeger KL; Hunter S; Heasley LE; Levresse V; Leon RP; DeGregori J; Anderson SM
Mol Endocrinol; 2000 Oct; 14(10):1592-602. PubMed ID: 11043575
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells.
Tsitoura DC; Rothman PB
J Clin Invest; 2004 Feb; 113(4):619-27. PubMed ID: 14966571
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
6. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
Yue J; Sun B; Liu G; Mulder KM
J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
[TBL] [Abstract][Full Text] [Related]
7. Jun and JNK kinase are activated in thymocytes in response to VM26 and radiation but not glucocorticoids.
Testolin L; Carson C; Wang Y; Walker PR; Armato U; Sikorska M
Exp Cell Res; 1997 Feb; 230(2):220-32. PubMed ID: 9024781
[TBL] [Abstract][Full Text] [Related]
8. Organization of mammary epithelial cells into 3D acinar structures requires glucocorticoid and JNK signaling.
Murtagh J; McArdle E; Gilligan E; Thornton L; Furlong F; Martin F
J Cell Biol; 2004 Jul; 166(1):133-43. PubMed ID: 15226308
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
10. The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter.
Berlanga JJ; Garcia-Ruiz JP; Perrot-Applanat M; Kelly PA; Edery M
Mol Endocrinol; 1997 Sep; 11(10):1449-57. PubMed ID: 9280060
[TBL] [Abstract][Full Text] [Related]
11. MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts.
Kesavan K; Lobel-Rice K; Sun W; Lapadat R; Webb S; Johnson GL; Garrington TP
J Cell Physiol; 2004 Apr; 199(1):140-8. PubMed ID: 14978743
[TBL] [Abstract][Full Text] [Related]
12. Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells.
Gutzman JH; Rugowski DE; Schroeder MD; Watters JJ; Schuler LA
Mol Endocrinol; 2004 Dec; 18(12):3064-75. PubMed ID: 15319452
[TBL] [Abstract][Full Text] [Related]
13. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.
Karin M; Gallagher E
IUBMB Life; 2005; 57(4-5):283-95. PubMed ID: 16036612
[TBL] [Abstract][Full Text] [Related]
14. Prolactin-dependent activation of a tyrosine phosphorylated DNA binding factor in mouse mammary epithelial cells.
Welte T; Garimorth K; Philipp S; Doppler W
Mol Endocrinol; 1994 Aug; 8(8):1091-102. PubMed ID: 7527899
[TBL] [Abstract][Full Text] [Related]
15. Thrombin-induced connective tissue growth factor expression in human lung fibroblasts requires the ASK1/JNK/AP-1 pathway.
Yu CC; Hsu MJ; Kuo ML; Chen RF; Chen MC; Bai KJ; Yu MC; Chen BC; Lin CH
J Immunol; 2009 Jun; 182(12):7916-27. PubMed ID: 19494316
[TBL] [Abstract][Full Text] [Related]
16. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
17. Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas.
Papachristou DJ; Batistatou A; Sykiotis GP; Varakis I; Papavassiliou AG
Bone; 2003 Apr; 32(4):364-71. PubMed ID: 12689679
[TBL] [Abstract][Full Text] [Related]
18. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
Yu W; Simmons-Menchaca M; You H; Brown P; Birrer MJ; Sanders BG; Kline K
Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids antagonize AP-1 by inhibiting the Activation/phosphorylation of JNK without affecting its subcellular distribution.
González MV; Jiménez B; Berciano MT; González-Sancho JM; Caelles C; Lafarga M; Muñoz A
J Cell Biol; 2000 Sep; 150(5):1199-208. PubMed ID: 10974006
[TBL] [Abstract][Full Text] [Related]
20. Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter.
Wei P; Inamdar N; Vedeckis WV
Mol Endocrinol; 1998 Sep; 12(9):1322-33. PubMed ID: 9731701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
